L

Lumicell

Intraoperative imaging system with cancer-targeting agents

Overview

Lumicell Diagnostics develops intraoperative imaging for cancer surgery. Its core product, the Lumicell Direct Visualization System (DVS), uses a hardware imaging platform paired with a proprietary fluorescent imaging agent to illuminate cancer cells in real time during surgery. The system helps surgeons identify and remove malignant tissue that is not visible to the eye, aiming to reduce positive margins and the need for repeat surgeries. The company differentiates itself by delivering an integrated hardware-and-agent solution for fluorescence-guided, real-time visualization in the operating room, with an initial focus on breast cancer and plans to expand to other cancer types, targeting commercialization at scale to improve surgical outcomes.

Work here?Claim your company

About Lumicell

Simplify's Rating
Not yet rated

We're working on gathering enough insights on this company, check back soon!

Industries

Data & AnalyticsHealthcare

Company Size

51-200

Company Stage

Grant

Total Funding

$83.9M

Headquarters

Waltham, MA

Founded

2009

Get referred to Lumicell

See people who can refer or advise you

Funding

Total Funding

$83.9M

Meets

Industry Average

Funded Over

10 Rounds

Grant funding comparison data is currently unavailable. We're working to provide this information soon!
Grant Funding Comparison Coming Soon

Growth & Insights

6 month growth

8%

1 year growth

17%

2 year growth

71%

Recently Posted Jobs

Sign up to get curated job recommendations

Lumicell is Hiring for 3 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs